5-Lipoxygenase inhibitors for the treatment of inflammatory bowel disease
- 1 July 1992
- journal article
- Published by Springer Nature in Inflammation Research
- Vol. 36 (3-4), C37-C46
- https://doi.org/10.1007/bf01996094
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Eicosanoids, epithelium and airway reactivityGeneral Pharmacology: The Vascular System, 1990
- Treatment of Ulcerative Colitis with Fish Oil n-3-ω-Fatty AcidJournal of Clinical Gastroenterology, 1990
- 2,3-Dihydro-5-benzofuranols as antioxidant-based inhibitors of leukotriene biosynthesisJournal of Medicinal Chemistry, 1989
- Biochemical Studies on Mammalian Lipoxygenases,bAnnals of the New York Academy of Sciences, 1988
- Chemotactic activity in inflammatory bowel diseaseDigestive Diseases and Sciences, 1987
- Inhibition of 5-lipoxygenase pathway of arachidonic acid metabolism in human neutrophils by sulfasalazine and 5-aminosalicylic acidDigestive Diseases and Sciences, 1987
- Biosynthesis of lipoxygenase and cyclo-oxygenase products from [14C]-arachidonic acid by human colonic mucosa.Gut, 1983
- Studies of prostaglandins and sulphasalazine in ulcerative colitisProstaglandins and Medicine, 1981
- Identification of the C(6)-S-conjugate of leukotriene a with cysteine as a naturally occurring slow reacting substance of anaphylaxis (SRS-A). Importance of the 11-cis-geometry for biological activityBiochemical and Biophysical Research Communications, 1980
- Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesNature, 1980